<?xml version="1.0" encoding="UTF-8"?>
<p>Didanosine is active against FIV 
 <italic>in vitro</italic> [
 <xref rid="B14-vetsci-02-00456" ref-type="bibr">14</xref>,
 <xref rid="B18-vetsci-02-00456" ref-type="bibr">18</xref>,
 <xref rid="B20-vetsci-02-00456" ref-type="bibr">20</xref>,
 <xref rid="B21-vetsci-02-00456" ref-type="bibr">21</xref>,
 <xref rid="B22-vetsci-02-00456" ref-type="bibr">22</xref>,
 <xref rid="B23-vetsci-02-00456" ref-type="bibr">23</xref>,
 <xref rid="B24-vetsci-02-00456" ref-type="bibr">24</xref>,
 <xref rid="B26-vetsci-02-00456" ref-type="bibr">26</xref>,
 <xref rid="B38-vetsci-02-00456" ref-type="bibr">38</xref>]. In one experimental 
 <italic>in vivo</italic> study, FIV replication was significantly suppressed in animals treated with didanosine, but treatment contributed to the development of antiretroviral toxic neuropathy [
 <xref rid="B39-vetsci-02-00456" ref-type="bibr">39</xref>].
</p>
